Biopharma | December 04, 2025
Aelis Farma gets EMA nod for phase 2B trial of AEF0217 in down syndrome
AEF0217 is a first-in-class CB1 receptor signaling-specific inhibitor
AEF0217 is a first-in-class CB1 receptor signaling-specific inhibitor
The company introduced the ExcelSign E12 and E17 modular patient monitors, the Relife 1000 biphasic defibrillator, and a new OT charting software
The platform integrates with CT imaging and uses deep learning models to generate a 3D digital twin of lung anatomy
Now a test that offers new precision in prostate cancer detection
Armlupeg is indicated for decrease the incidence of infection, as manifested by febrile neutropenia, in patients with nonmyeloid malignancies receiving myelosuppressive anti-cancer drugs
The 7,000th store was inaugurated in Ayodhya, Uttar Pradesh
Renalyx will continue operating as an independent unit within the group
Sac-TMT is a novel human TROP2 ADC with proprietary intellectual property, targeting advanced solid tumors
The viewer aims to help radiologists work smarter, faster, and more collaboratively, while reducing IT complexity and freeing up valuable clinical time
Owlet’s push comes as parents demand smarter, more dependable nursery tech
Subscribe To Our Newsletter & Stay Updated
